ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709103; 2) Community: the network communities that were significantly associated with the response to NSC 709103; 3) Molecule: the relationships between components within communities and NSC 709103; 4) MDR: the compounds that were significantly associated with the NSC 709103.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.024225674400439 0.26098599
NSC 209835 [11]Cytochalasa-6(12),13,19-triene-1,17-dione, 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E,21R)- (9CI) 0.0257805259050655 0.046811024
NSC 321521 SK&F 39162 0.0257805259050655 0.28961323
NSC 335787 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide 0.0257805259050655 0.34547253
NSC 408191 Null 0.0257805259050655 0.37670162
NSC 620462 Null 0.0257805259050655 0.28219456
NSC 622626 Null 0.0257805259050655 0.36074761
NSC 635157 Dichlorobisoxinatotitanium(IV) 0.0257805259050655 0.29095161
NSC 680410 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) 0.0257805259050655 0.28744236
NSC 729792 N-[4-(1H-benzo[d]imidazol-2-yl)phenyl]-N'-(4-chlorophenyl)im idoformamide 0.0269205957264771 0.30832638
Total:35  Current:15    [First] [Prev] [Next] [Last]